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Introduction
Testis cancer rates have increased in western countries
although with signiﬁcant variations between countries
(Chia et al., 2010; Engholm et al., 2010). Thus, for several
decades, the incidence rates among Finnish men were
lower than for men from most other countries, and at the
same time, the Finnish men were found to have higher
sperm counts than men from other Nordic countries
(Vierula et al., 1996; Jørgensen et al., 2002). However,
recent publications have indicated a change towards
accelerated testis cancer rates among Finns (Richiardi
et al., 2004).
Testis cancer and other male reproductive problems
including impaired semen quality have been suggested to
be linked through a testicular dysgenesis syndrome of
foetal origin due to impact of environmental factors
(Skakkebæk et al., 2001). Thus, such reproductive health
problems may be related to year of birth, although not
manifested until adulthood.
A question is whether the reported better reproductive
health of Finnish men could be due to different environ-
mental exposures or caused by genetic differences. We
hypothesized that the better situation in Finland could be
due to the fact that Finland ‘lagged behind’ in exposures
to modern industrial pollution. Therefore, we carried out
semen studies on cohorts of young Finnish men, and a
registry study of testis cancer to explore recent temporal
trends.
Materials and methods
Semen quality study
The inclusion criteria and investigation methods of the
young Finnish men were similar to those applied in the
previously published studies (Jørgensen et al., 2002).
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Summary
Impaired semen quality and testicular cancer may be linked through a testicu-
lar dysgenesis syndrome of foetal origin. The incidence of testis cancer has been
shown to increase among Finnish men, whereas there is no recent publication
describing temporal trends in semen quality. Therefore, we carried out a pro-
spective semen quality study and a registry study of testis cancer incidence
among Finnish men to explore recent trends. A total of 858 men were investi-
gated in the semen quality study during 1998–2006. Median sperm concentra-
tions were 67 (95% CI 57–80) million⁄mL, 60 (51–71) and 48 (39–60) for
birth cohorts 1979–81, 1982–83 and 1987; total sperm counts 227 (189–
272) million, 202 (170–240) and 165 (132–207); total number of morphologi-
cally normal spermatozoa 18 (14–23) million, 15 (12–19) and 11 (8–15). Men
aged 10–59 years at the time of diagnosis with testicular cancer during 1954–
2008 were included in the registry study, which conﬁrmed the increasing inci-
dence of testicular cancer in recent cohorts. These simultaneous and rapidly
occurring adverse trends suggest that the underlying causes are environmental
and, as such, preventable. Our ﬁndings necessitate not only further surveillance
of male reproductive health but also research to detect and remove the under-
lying factors.
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Finnish young men are required to attend a medical
examination when they are 18 or 19 years. Such groups
can be considered representative of the general popula-
tion, and we invited all such men to our study utilizing
the same drafting lists irrespective of whether the men
were ﬁt or unﬁt for military service. Hence, all men were
sent a letter inviting them to join the present study, with
replies returned either over the telephone or by post. Fur-
ther inclusion criteria were that the men lived in the
Turku area in Finland and that they and their mothers
were born in Finland. For men agreeing to participate, a
subsequent appointment for examination at the Turku
University Andrology Unit in the Institute of Biomedicine
was made. Each participant completed a questionnaire
(including information on age, previous or current dis-
eases and some life-style factors), underwent a physical
examination, provided a semen sample and received
ﬁnancial compensation (40–50 Euro). The study period
was 1998–2006. Altogether, 858 men were investigated.
Results for 324 of these have previously been reported
(Jørgensen et al., 2002), but were also included here to
describe temporal changes. The participation rate was
13.4%.
A description of the study population based on question-
naire information and results from the physical examina-
tion is given in Table 1. The three types of information in
Table 1 ‘Been diagnosed as having’, ‘Been treated for’ and
‘Has’ are based on questions phrased as ‘Has a doctor ever
diagnosed you as having…’, ‘Have you ever been treated
for…’ and ‘Have you ever…’respectively. During the pre-
ceding 3 months to participation in the study, 17.6% had
used medication, which mainly were antibiotics, painkil-
lers, asthma or allergy medicine. Prior to participation in
the study, 1.2% of the men had been diagnosed with a vari-
cocoele and 0.8% had been operated. Few men had been
treated for a disease of penis, urethra or scrotum (Table 1).
All speciﬁed treatments were due to phimosis. None of the
men answered positively to have been treated for hypospa-
dias. During the physical examination, the penises of all
men were classiﬁed as normal, and without signs of previ-
ous treatments of hypospadias, and none was diagnosed
with hypospadias.
A subgroup of men who had not taken any medicines
and were without any previous or current andrological
diseases, infertility problems or known fertility were
deﬁned, and they constituted 63.2% of the entire study
group (Table 1).
Semen samples
Semen samples were obtained by masturbation in the pri-
vacy of a room adjacent to the laboratory. Ejaculation
abstinence of at least 48 h was recommended and the
abstinence periods as reported by the men were recorded.
Semen volume was estimated by weighing. For sperm
motility assessment, duplicates of 10 lL of well-mixed
semen were placed on a glass slide, examined under a
microscope at ·400 magniﬁcation and spermatozoa were
classiﬁed as motile or immotile. The average of the two
countings was used. For the assessment of the sperm con-
centration, the samples were diluted in a solution of
0.6 mol⁄L NaHCO3 and 0.4% (v⁄v) formaldehyde in dis-
tilled water, and subsequently assessed using an improved
Neubauer haemocytometer. Finally, smears were prepared,
Papanicolaou stained and assessed according to strict cri-
teria (Menkveld et al., 1990). The same technician
assessed semen volume, sperm motility and concentration
during all the study years. Assessments of morphology
were performed by one investigator (MV) at the end of
the study period. Thus, also samples that previously had
been assessed by another investigator (Jørgensen et al.,
2002) were reassessed.
A continuous external quality control programme for
assessment of sperm concentration (Jørgensen et al., 2002;
Punab et al., 2002; Paasch et al., 2008) was performed. In
the period 1998–2006, ﬁve quality control samples were
sent to the participating centres including the Turku labo-
ratory 8–10 times yearly, and assessed as described above.
Thus, in the study period, more than 400 samples were
assessed in the QC programme. The results showed that
the Turku laboratory constantly assessed 11% higher than
the Copenhagen reference laboratory (95% conﬁdence
interval 2–22%, p = 0.02), consistent with the result pre-
viously reported (Jørgensen et al., 2002). Thus, for
description of temporal changes, no adjustments accord-
ing to these quality control results were needed because
of the constant level.
Physical examination
Testis sizes were measured using a Prader orchidometer,
presence of varicocoele or other scrotal abnormalities and
the Tanner stage of pubic hair was evaluated. Body height
and weight were measured, and body mass index (BMI)
was calculated. One physician undertook 82% and
another 15% of the examinations, and the deputies, the
remaining 3%.
Participants vs. non-participants
Information about the total number of eligible men and
zip-code of their current place of living was obtained.
Statistical analysis – semen study
Standard statistics (mean, median, standard deviation
(SD), 5–95 percentiles and frequencies) were used for
basic descriptions. The study subjects were described as
three groups depending on the investigation periods: ﬁrst
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2000), second group 2001–2003 (examined December
2000 to April 2003) and third group 2006 (examined
April 2006 to January 2007). Between-group differences
for continuous variables were tested using the non-para-
metric Kruskal–Wallis test. Between-group differences for
categorical variables were tested using the Pearson chi-
squared test.
The main outcome variables were the semen variables.
Both temporal trends according to the investigation peri-
ods and according to birth cohorts (described as three
groups born 1979–81, 1982–83 and 1987 respectively)
were tested by multiple linear regressions adjusted for
confounders. Semen volume, sperm concentration and
total sperm counts were normalized by cubic root trans-
formation before analysis to correct for skewed distribu-
tion of residuals. The percentages of motile spermatozoa
were logit-transformed. Percentages of morphologically
normal spermatozoa entered the model untransformed.
Ejaculation abstinence up to 96 h had an increasing effect
on semen volume, sperm concentrations and total sperm
counts (all p < 0.05), and was entered as a covariate in
the regression analyses of these variables, whereas it had
no effect on either morphology or motility. There was a
tendency for increasing frequency of morphologically nor-
mal spermatozoa with increasing age (beta 0.59% per
year), although non-signiﬁcant (p = 0.17). However, in
the ﬁnal models, all semen variables were adjusted for
age. Season of year was evaluated as a possible con-
founder for all the semen variables. For sperm motility,
duration from ejaculation to assessment was additionally
evaluated as a confounder. Both were non-signiﬁcant and
therefore not included.
Natural logarithmic transformation gave models in
which period differences and effects of covariates are
more easily interpretable. This alternative model approxi-
mates closely the model obtained by cubic root transfor-
mation and is used when reporting adjusted semen
volumes, sperm concentrations, total sperm counts and
total number of morphologically normal spermatozoa,
adjusted to represent a 19-year-old man having an ejacu-
lation abstinence period of 96 h. The logit-transformed
motility data and untransformed morphology percentages
were used to give adjusted levels for a 19-year-old man
for these variables.
p < 0.05 was considered statistically signiﬁcant. Analy-
ses were performed using PASW GradPack 18.0 (SPSS
Inc., Chicago, IL, USA).
Registry study of testicular cancer
Data on incident testicular cancer cases were gathered
from the Finnish Cancer Registries. In the period 1954–
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Among these, 484 were younger than 10 years-old and
264 were aged more than 60 years. The remaining
(N = 5226) were included for calculation of age-speciﬁc
and age-adjusted incidence rates (per 100000) and
described by cumulated incidence rates for men from the
whole of Finland, and for the Turku region (the part of
the South-West part where the semen quality study
was undertaken). Among the 5226 men, 1820 were
aged 10–19 years, 1804 20–29 years, 886 30–39 years, 478
40–49 years and 238 50–59 years at the time of diagnosis
of testicular cancer. From the Turku area, of the 800 men
aged 10–59 years who were diagnosed with testicular
cancer in 1954–2008, 282 were aged 10–19 years, 270
20–29 years, 128 30–39 years, 92 40–49 years and 28
50–59 years. Approximate birth cohorts born in 1930–38
were used for the analyses of the age-speciﬁc trends. Birth
cohorts were computed for men aged 10–59 years.
Results
Study population
When testing for differences in physical appearance and
self-reported information, only age differed signiﬁcantly
among the three study groups (Table 1). The following
pair-wise testing showed this to be caused by the ﬁrst
study group that was marginally younger than the latter
two (18.8 vs. 19.1 years). Otherwise, there were no signiﬁ-
cant differences between the groups in physical appear-
ance, life-style or medical history.
Semen quality study
Semen quality
Semen results according to investigation periods are
shown in Table 2. ‘Observed’ values are based on raw
data, and ‘Adjusted’ are the confounder-adjusted esti-
mates obtained from regression analyses. The median
ejaculation abstinence was 65 h (64, 65 and 67 for the
groups 1998–99, 2001–03 and 2006 respectively). Semen
volume did not differ among the three investigation peri-
ods, whereas sperm concentration, total sperm counts,
percentage of morphologically normal spermatozoa and
total number of morphologically normal spermatozoa all
decreased. The percentages of motile spermatozoa varied
without any speciﬁc trend (medians 65–74%). The same
calculations as presented in Table 2 were made on the
subgroup of men not affected by any of the conditions
deﬁned in Table 1, and for this subgroup, a temporal
trend similar to that for the entire study population was
seen (Table 3).
For the entire study group, 13 and 36% had sperm
concentrations below 15 and 40 million⁄mL, and 55 and
86% had less than 9 and 12% morphologically normal
spermatozoa respectively.
The birth years for the participants ranged from 1979 to
1987; 39, 45 and 16% were born in 1979–81, 1982–83 and
1987, respectively. Figure 1 illustrates the adjusted levels of
sperm concentrations, total sperm counts and morphology
according to the birth year categories in contrast to the
Tables where the results were stratiﬁed according to the
investigation period. The most recently born men had
lower levels of semen variables than the earliest born.
Based on men who had ejaculation abstinence of at least
48 h, Fig. 2 illustrates that the frequencies of men having
sperm concentrations below 15 million⁄mL and in the
range 15–40 million⁄mL increased in the recent birth
cohorts.
Men who reported that their mothers had been smok-
ing during pregnancy (N = 10.2%) did not signiﬁcantly
differ for their semen variables from non-exposed men
(adjusted median semen volume 3.1 vs. 3.4 mL, p = 0.3;
total sperm count 207 vs. 209 million, p = 0.6; percent
motile spermatozoa 67 vs. 69%, p = 0.3; sperm concen-
tration 64 vs. 62 million⁄mL, p = 0.8; percentage of mor-
phologically normal spermatozoa 8.6 vs. 8.6%, p = 0.9).
Similarly, the men’s own smoking or drinking habits did
not affect the semen variables.
The participants were categorized into two based on
their current place of living, Turku City and surrounding
areas (neighbouring municipalities Kaarina and Raisio).
Men from ‘surrounding areas’ had a frequency of motile
spermatozoa at 72%, p = 0.001, in comparison with men
living in Turku City (comparison level 100%). No effect
of place of living could be detected for other semen vari-
ables, p = 0.4–0.9.
Physical examination
The median (5–95 percentiles) sizes of the left and right
testes were 20 mL (14–27 mL) and 22 mL (15–30 mL);
99.5% of the men had normal pubic hair development
(Tanner stage 5 or 6).
Registry study of testicular cancer
Figure 3 shows that the annual testicular cancer inci-
dences from 1954 to 2008 increased more in the Turku
area (which is a part of the South-Western area) of
Finland than in the entire country. To study the
age-dependent temporal trends, we analysed age-adjusted
(5-years-age intervals 10–14 years, 15–19 years etc) inci-
dence rates for the entire Finland and the Turku region
(Fig. 4). The recent birth cohorts have an increased inci-
dence of testicular cancer compared with previous cohorts
irrespective of age of cancer diagnosis, except for men
aged 10–14 years.
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The investigation of men from the general population of
young Finns from the Turku area showed lower sperm
counts in the most recent birth cohort compared with
only few years older cohort. Additionally, the younger
and more recently born men also had higher incidences
of testis cancer than the older generations. This increase
seemed more pronounced for men from the Turku area
where the semen quality study was undertaken than for
the entire Finnish population. Thus, the currently young
Finnish men in general may suffer from more reproduc-
tive health problems than previous cohorts.
We described the detected adverse trends both as a
birth cohort phenomenon and as an effect related to the
study period. The birth cohort and investigation period
are linked, and statistical evaluations cannot help distin-
guish which is most relevant. However, the risk of testis
cancer is linked to birth cohorts (Bergstro ¨m et al., 1996),
and the incidence rate is 8–10 times higher for Finns
born around 1980 compared with men born around 1950
(Bray et al., 2006). Furthermore, testicular germ-cell can-
cers in adults arise from carcinoma-in situ cells which are
of foetal origin (Skakkebæk et al., 1987; Jørgensen et al.,
1995a,b; Rajpert-De Meyts, 2006; Sonne et al., 2009).
Thus, the increase in the testicular cancer incidences
should be interpreted as a birth cohort effect.
The described increase for the testicular cancer inci-
dence for the youngest men relies on only a rather small
number of men and should therefore be interpreted cau-
tiously. Nevertheless, we ﬁnd it striking that there seems
to be a tendency for an increased risk in all age groups
above 15 years old and a higher increase in the Turku
area than in the entire country. However, the results can
only be regarded as preliminary, and a longer observation
period is needed to corroborate or refute whether the
indicated trends will last. Nevertheless, the ﬁndings can
be used as an important indication of the validity of the
Table 2 Semen quality of young men from the Turku area in Finland
Observed Adjusted p-values comparing investigation periods
A
Mean (SD) Median (5–95) Median (95% CI) All periods 2006 vs. 2001–03 2006 vs. 1998–00
Semen volume (mL):
Investigation period 1998–99 3.3 (1.4) 3.0 (1.3–5.6) 3.4 (3.1–3.7) 0.99 0.97 0.97
Investigation period 2001–03 3.3 (1.5) 3.1 (1.2–6.1) 3.4 (3.1–3.6)
Investigation period 2006 3.4 (1.5) 3.3 (1.3–6.3) 3.3 (3.0–3.7)
Sperm concentration (million⁄mL):
Investigation period 1998–99 71 (59) 60 (3–185) 67 (57–80) 0.04 0.02 0.02
Investigation period 2001–03 68 (65) 54 (5–167) 60 (51–71)
Investigation period 2006 58 (50) 50 (1–141) 48 (39–60)
Total sperm count (million):
Investigation period 1998–99 219 (175) 193 (12–519) 228 (190–274) 0.07 0.04 0.03
Investigation period 2001–03 212 (201) 174 (17–522) 201 (169–238)
Investigation period 2006 183 (140) 156 (2–450) 165 (132–207)
Normal morphology (%):
Investigation period 1998–99 9.7 (5.3) 9.0 (2.0–19.2) 9.8 (9.2–10.4) 0.05 0.3 0.03
Investigation period 2001–03 9.1 (5.3) 8.5 (1.7–18.5) 9.1 (8.5–9.7)
Investigation period 2006 8.7 (4.9) 8.5 (1.5–18.0) 8.6 (7.6–9.5)
Total normal spermatozoa (million):
Investigation period 1998–99 24 (25) 17 (0.6–70) 18 (14–23) 0.02 0.09 0.006
Investigation period 2001–03 22 (30) 14 (0.5–62) 15 (12–19)
Investigation period 2006 18 (18) 10 (0.4–55) 11 (8–15)
Motile (%):
Investigation period 1998–99 63 (15) 66 (37–80) 65 (63–66) <0.0005 0.7 <0.0005
Investigation period 2001–03 72 (13) 75 (45–86) 74 (72–75)
Investigation period 2006 70 (19) 74 (31–89) 73 (71–74)
Observed: Results based on raw data.
SD: Standard deviation; 5–95: 5–95 percentiles.
Adjusted median and 95%CI (conﬁdence interval) calculated by linear regression analysis.
Sperm concentration, total sperm and semen volume adjusted to a period of ejaculation of 95 h for a 19-year-old man. Motility and morphology
were also adjusted to represent a 19-year-old man. See text for further details.
ALinear regression analyses, adjusted for co-variates as described above.
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opposite results). Most testicular cancers arise in men
10–60 years-old (Møller, 2001), which we also detected in
the current study. A vast majority of tumours in this
age-group are germ-cell tumours (>95%) arising from
carcinoma-in situ cells, whereas those arising at earlier or
later age have a different origin (Jørgensen et al. 1995a,
Rajpert-De Meyts, 2006). We could not separate the regis-
try information into germ-cell tumours or other testicular
tumour types and therefore we chose to show the inci-
dence only for men 10–59 years, which thus can be
expected to represent mainly trends for germ-cell
tumours.
The TDS concept proposes that an impaired develop-
ment of foetal testes may lead to an increased risk of
cryptorchidism, hypospadias, testicular cancer and
decreased spermatogenesis (Skakkebæk et al., 2001), but
does not imply that all affected men develop all the four
symptoms (Jørgensen et al., 2010). Animal studies illus-
trate that in utero exposures to anti-androgenic agents
may reduce Sertoli cell numbers that are the major factor
determining sperm count in an individual (Scott et al.,
2007; Sharpe, 2010). Interestingly, a continued post-natal
exposure was needed to suppress a post-natal recovery of
Sertoli cells after pre-natal exposure to an anti-androgen
(Auharek et al., 2010). This indicates that both pre- and
post-natal exposures are needed to affect Sertoli cell num-
ber permanently, at least if gross abnormalities are other-
wise not present. Thus, the low sperm counts may be the
result of both pre- and post-natal events.
An increasing number of the young Finns had a sperm
concentration below the new WHO reference level of
15 million⁄mL (World Health Organization, 2010). From
a biological point of view, this cut-off level may be too
low to indicate normal fecundity (Skakkebæk, 2010)
because the chances of achieving a pregnancy decrease
with sperm concentrations below 40 million⁄mL (Bonde
et al., 1998). A suggestion of a higher borderline value
was also corroborated by a study of European fertile men
showing a decrease in waiting time to pregnancy (TTP)
with increasing sperm concentration up to 55 million⁄mL
(Slama et al., 2002). An American study showed that only
men with a sperm concentration of more than 48 mil-
lion⁄mL could be classiﬁed as having a normal fertility
chance (Guzick et al., 2001). Taken together, this may
indicate that the 15% from the latest birth cohort having
less than 15 million⁄mL may get difﬁculties in fathering
children by natural means and that the remaining 28%
(difference up to 43%) that have less than 40 million⁄mL
may experience a longer waiting time to pregnancy than
men having higher sperm concentrations. It can be
argued that total sperm counts better reﬂect spermatogen-
esis than sperm concentrations. In the current study, we
did not see any change in semen volume and therefore
Table 3 Semen quality of the entire study group young men (‘all men’) from the Turku area in Finland, and a subgroup of these without previ-
ous or current conditions that potentially could affect the semen quality
Adjusted median (95% CI) for investigation periods
1998–99 2001–03 2006
Semen volume (mL):
All men 3.4 (3.1–3.7) 3.4 (3.1–3.6) 3.3 (3.0–3.7)
Subgroup 3.4 (3.0–3.7) 3.4 (3.1–3.8) 3.4 (3.0–3.9)
Sperm concentration (million⁄mL):
All men 67 (57–80) 60 (51–71) 48 (39–60)
Subgroup 65 (52–819 58 (47–72) 48 (36–64)
Total sperm count (million):
All men 228 (190–274) 201 (169–238) 165 (132–207)
Subgroup 218 (173–275) 200 (160–249) 172 (128–231)
Normal morphology (%):
All men 9.8 (9.2–10.4) 9.1 (8.5–9.7) 8.6 (7.6–9.5)
Subgroup 9.8 (9.0–10.6) 9.0 (8.3–9.7) 8.9 (7.6–10.1)
Total normal spermatozoa (million):
All men 18 (14–23) 15 (12–19) 11 (8–15)
Subgroup 18 (14–25) 15 (11–20) 13 (9–20)
Motile (%):
All men 65 (63–66) 74 (72–75) 73 (71–74)
Subgroup 65 (63–67) 74 (72–76) 73 (71–76)
For deﬁnition of the subgroup, see Table 1.
Adjusted median and 95% CI (conﬁdence interval) calculated by linear regression analysis.
Sperm concentration, total sperm and semen volume adjusted to a period of ejaculation of 95 h for a 19-year-old man. Motility and morphology
were also adjusted to represent a 19-year-old man. See text for further details.
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whether sperm concentrations or total sperm counts were
investigated.
The high number of morphologically abnormal sper-
matozoa of the young men also indicated that reduced
fecundity may be a frequent problem. According to
Guzick et al. (Guzick et al., 2001), who used sperm
morphology – assessed according to the same criteria as
here – a man should have at least 12% normal spermato-
zoa to be classiﬁed as fertile. This was the case only for
26% of the men. van Waart et al. detected a reduced
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Figure 1 Sperm concentrations, total sperm counts and morphology
according to year of birth of men representative of the general young
Finnish population. The ﬁgures represent medians adjusted for con-
founders and 95% conﬁdence intervals. The most recently born men
had signiﬁcantly lower levels than the earliest born men.
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Figure 2 Frequencies of young Finnish men having sperm concentra-
tions below 15, 15–40 and above 40 million⁄mL in three birth
cohorts. Note the trends for more men having sperm concentrations
below 40 million⁄mL; 31, 35 and 43% for the birth cohorts 1979–81,
1982–83 and 1987 respectively.
Figure 3 Testis cancer incidences for Finnish men, 10–59 years old at
time of diagnosis, according to year of diagnosis and region. Overall,
there has been an increasing incidence during the recent 50 years,
however, more pronounced in the Turku area where the semen qual-
ity studies, illustrated in Figs 1 & 2, have been undertaken.
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frequency of normal spermatozoa was below 5% (van
Waart et al., 2001). Thus, the approximately 22% of the
young Finns in our study who had less than 5% normal
forms also showed an impaired quality for this important
variable for fecundity.
Special caution is needed in the interpretation of the
sperm motility data. Sperm motility assessment is highly
subjective, and it was not possible for us to undertake a
quality control study of the assessment of this variable.
However, the distinction between motile and immotile
spermatozoa may be more reliable than distinction
between different subcategories of motilities (Jørgensen
et al., 1997), which is the reason why we have only pre-
sented the frequencies of motile spermatozoa.
Only one technician was involved in the study reduc-
ing the potential impact by inter-observer variation. The
quality control programme showed this technician to
assess sperm concentration at a constant level during the
years when compared with other participants in the pro-
gramme. Thus, within-observer variation did not explain
the detected trends in sperm count. However, to make
the described results directly comparable to those
published previously from similar studies from other
countries and the initial Finnish study (Jørgensen et al.,
2002; Punab et al., 2002; Paasch et al., 2008), a correc-
tion has to be applied. These previously published results
used the Copenhagen laboratory as reference and
adjusted the sperm concentration to the Copenhagen
assessment level. Thus, the currently provided results for
sperm concentration, total sperm count and total num-
ber of morphologically normal spermatozoa should be
corrected for the assessment difference of 11% according
to the quality control results given in the Materials and
methods section (e.g. corrected sperm concentra-
tion = observed sperm concentration ·100⁄111). The
effects of potential confounders were accounted for in
the statistical analyses, when relevant. The inﬂuence of
increasing duration of abstinence up to approximately
96 h for semen volume, sperm concentration and total
sperm count, and no effect on motility or morphology
is in agreement with our initial ﬁndings, and with the
results of other semen quality studies of men from the
Northern European area (Jørgensen et al., 2002; Punab
et al., 2002; Paasch et al., 2008). Other studies have
shown an adverse effect of maternal smoking during
pregnancy on the son’s semen quality (Jensen et al.,
2004, 2005; Paasch et al., 2008). In contrast, we did not
Figure 4 The testis cancer incidences, according to both years of birth and age at time of diagnosis for the cancer patients stratiﬁed according
to the same geographical regions as in Fig. 3. Except for men aged 10–14 years, the recent birth cohorts have an increased incidence of testicular
cancer compared with previous cohorts irrespective of age of cancer diagnosis. However, the results for the most recent cohorts should be inter-
preted cautiously because of relatively small numbers of men in each sub-group.
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of smoking mothers was very small.
Despite the participation being low, as it often is in
studies requesting delivery of semen, we considered the
examined men as representative of the normal population
of young men from the Turku area. The men had essen-
tially no prior knowledge of their own fertility potential
and therefore attention to possible fertility problem is
unlikely to have affected their motivation to participate.
As shown in Table 3, the same trends in semen parame-
ters was detected when the analysis was based only on
men without any known ‘conditions’ as detailed in
Table 1. This indicates that such ‘conditions’ were not the
reason for the detected trends. The ﬁnancial compensa-
tion received for participating in the study seems unlikely
to have led to the selection of men with reduced semen
quality. In fact, if compensation had not been given, it is
most likely that men suffering from some kind of disease
would be more interested in participating – in the hope
of receiving advice – than men without diseases. Further-
more, a Danish study evaluating the reproductive hor-
mones FSH, inhibin-B, LH and testosterone detected that
the levels of these hormones did not differ between men
who delivered semen samples and a larger group of men
who only had a blood sample drawn (Andersen et al.,
2000). This indicates that men who participate in a semen
quality study using our approach do not differ from non-
participants when their testicular functions are assessed
according to hormonal levels, indicating that the partici-
pation rate does not hamper conclusions from the
obtained results.
In addition to previously described differences in the
testicular cancer rates and semen quality between Finnish
men and Danish men (Jørgensen et al., 2002; Chia et al.,
2010), we have shown a signiﬁcant difference in the prev-
alence of cryptorchidism and hypospadias in boys born in
1997–2001 in Copenhagen and Turku (Virtanen et al.,
2001; Boisen et al., 2004, 2005). Danish boys had a higher
incidence of these disorders. Furthermore, Finnish boys
with normal testicular descent had larger testes and
higher inhibin-B values at 3 months of age than healthy
Danish boys (Main et al., 2006). These ﬁndings suggested
to us that we may see similar differences between the
countries when the boys mature to adult age; i.e. better
semen quality in Finns than in Danes. As the present data
on semen quality show deterioration of semen quality in
Finnish men born 10–20 years earlier than the 1997–2001
cohort, we might see deterioration also in the Danish
group in the future.
The factors causing the adverse trends in male repro-
ductive health remain elusive. However, only environ-
mental factors can explain the rapidly increasing trends in
testicular cancer. Factors related to modern way of living
may be involved, including exposure to modern industrial
chemicals and pesticides. Recent experimental research
has revealed that the foetal gonads are particularly vulner-
able to endocrine disruption (Auharek et al., 2010; Fisher
et al., 2003; Mahood et al., 2005, 2006). Whatever the
cause may be, most likely we should search for complex
factors operating 20–30 years ago to explain the current
reproductive problems of young men. Some Western
European countries experienced more rapid post-war
industrial development than Finland, which nevertheless
more recently has enjoyed a very high economic growth.
Today, Finland and other Western European countries
are rather similar with regard to industrialization and
economy (Statistical Yearbook of Finland, 2006). Our
results seem to indicate that Finland will also adapt to
these European countries with regard to male reproduc-
tive health.
In conclusion, our surveillance study revealed that the
semen quality of recent birth cohorts of Finnish men
seemed to deteriorate. In addition, an increase in the inci-
dence of testis cancer was apparent and more pronounced
for men from the Turku area of Finland where the semen
studies were undertaken. We speculate that the simulta-
neous adverse trends in semen quality and testis cancer
could be linked through an increasing frequency of men
with testicular dysgenesis syndrome among Finnish men.
The rapid rate of changes may suggest that the underlying
causes are environmental and, as such, preventable. Our
ﬁndings necessitate not only further surveillance of male
reproductive health but also more research efforts to
detect and remove the environmental factors which most
likely are behind these ﬁndings.
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